McKesson Pays $190M To End Drug Price Inflation Claims

Law360, New York (April 26, 2012, 4:35 PM EDT) -- Pharmaceutical distributor McKesson Corp. will pay the federal government $190 million to settle allegations it fraudulently inflated pricing information for several brand-name prescription drugs, causing Medicaid to overpay for those drugs, the U.S. Department of Justice said Thursday.

The government alleged that McKesson knowingly inflated the so-called average wholesale price for the drugs it reported to First Databank Inc., a company that publishes drug price data, between 2001 and 2005 — allegations that have already resulted in a slew of similar lawsuits filed against McKesson, as...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.